Lv1
50 积分 2022-12-04 加入
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
1个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
1个月前
已完结
Controlled Fab-arm exchange for the generation of stable bispecific IgG1
2个月前
已完结
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
2个月前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
6个月前
已完结
皖公网安备34019202002308
